等待开盘 11-17 09:30:00 美东时间
-0.150
-3.84%
The latest announcement is out from Aquestive Therapeutics ( ($AQST) ). On Nove...
11-16 19:58
11月14日,Aquestive Therapeutics Inc.(AQST)收涨9.52%,报3.91美元,成交额1522.02万美元,市值4.91亿美元...
11-14 07:07
11月12日,Aquestive Therapeutics Inc.(AQST)收涨1.7%,报3.58美元,成交额784.07万美元,市值4.5亿美元。 行情...
11-12 07:10
Aquestive Therapeutics ( ($AQST) ) has shared an announcement. Aquestive Therap...
11-06 06:57
Aquestive Therapeutics announced that multiple presentations on its investigational product Anaphylm™ (dibutepinephrine) sublingual film will be featured at the 2026 ACAAI Annual Meeting in Phoenix. The presentations will focus on pharmacokinetics, pharmacodynamics, and healthcare provider perspectives on epinephrine delivery for anaphylaxis treatment. Anaphylm, a polymer-based epinephrine prodrug, is designed as an oral rescue medication for sev...
11-05 12:00
11月5日,Aquestive Therapeutics Inc.(AQST)收跌2.06%,报3.8美元,成交额1292.99万美元,市值4.77亿美元。 行...
11-05 07:09
Aquestive Therapeutics ( ($AQST) ) has issued an announcement. On September 16,...
11-04 06:20
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $51.040 million estimate.
11-04 05:03
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 7.14 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $7.557...
11-04 05:02
11月3日,Aquestive Therapeutics Inc.(AQST)收跌3.08%,报3.77美元,成交额986.55万美元,市值4.73亿美元。 行...
11-03 07:06